Health Technologies and Pharmaceuticals. Annual Report 2016 (2017)
The WHO Regional Office for Europe, through the Health Technology and Pharmaceuticals (HTP) programme, supports its 53 Member States in providing people with sustainable access to essential and affordable quality medicines and medical products.
In 2016, the HTP programme of work contributed to strengthening countries’ pharmaceutical sector systems through technical advice on selection and responsible use of medicines, support to national regulatory authorities, the development or revision of national pharmaceutical policies, expanding the use of Health Technology Assessment (HTA), developing medicine pricing policies, and in new directions in procurement and supply chain management.
This report summarizes the 2016 contribution of the HTP programme to improving health in the WHO European Region, by supporting improved access to essential, affordable, quality pharmaceuticals and medical products.